I think he's said both in different contexts
Renal and glio were the two assets the company started with.
Renal is "his baby" because it's the first product that Telix have fully taken to market with their own Ph III trial (as opposed to buying the ANMI Ph III prostate data.)
But with Pixclara, he's said several times that it's the "dark horse" of the company that doesn't get much attention. And that he just really likes it.
I think he's said both in different contexts Renal and glio were...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.19 |
Change
0.780(4.24%) |
Mkt cap ! $6.421B | |||
| Open | High | Low | Value | Volume |
| $18.85 | $19.19 | $18.78 | $22.02M | 1.155M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2216 | $19.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.20 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| TLX (ASX) Chart |